Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New PLA2 inhibitor protects liver against I/R injury in canine model

Sep. 12, 2000

UR-12746, a novel IBD candidate

Sep. 8, 2000

Licensing opportunity from NIH: cloned genomes of infectious GB virus B

Sep. 8, 2000

Licensing opportunity from NIH: HCV and bovine viral diarrhea virus chimeric genomes

Sep. 6, 2000

Licensing opportunity from NIH: cloned hepatitis C virus genome

Sep. 6, 2000

XTL Biopharmaceuticals and Hybrigenics to codevelop novel HCV therapeutics

Sep. 5, 2000

C. difficile toxin binding polymer demonstrates tolerability in phase I trial

Sep. 4, 2000

FXR ligands synthesized by Glaxo Wellcome

Aug. 31, 2000

InKine changes trade name of Diacol to Visicol

Aug. 29, 2000

New compounds interacting with opioid receptors useful for IBS, etc.

Aug. 28, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...